Made available in DSpace on 2014-06-11T19:28:22Z (GMT). No. of bitstreams: 0 Previous issue date: 2006-07-07Bitstream added on 2014-06-13T19:57:41Z : No. of bitstreams: 1 buzzulini_c_me_jabo.pdf: 351448 bytes, checksum: e6056ca6a3d652168a92e26484bf6b71 (MD5) / Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) / Para avaliar a eficácia anti-helmíntica da associação Albendazole, Levamisole e Ivermectina comparativamente a Moxidectina 1% foram realizados dois experimentos utilizando ovinos naturalmente infectados por nematódeos gastrintestinais. No primeiro teste, 24 ovinos foram distribuídos em três tratamentos experimentais com oito animais cada, assim definidos: T1 ovinos tratados com a associação Albendazole, Levamisole e Ivermectina; T2 ovinos tratados com Moxidectina 1% e T3 ovinos sem tratamento anti-helmíntico (controle). Contagens de ovos por grama de fezes (OPG) foram realizadas nos dias 1, 3, 5 e 7 após os tratamentos e, nesta última data, todos os ovinos foram necropsiados, sendo quantificados e identificados, quanto ao gênero e espécie, todos os helmintos encontrados no trato gastrintestinal. Tanto na redução de OPG quanto na eficácia contra as diferentes espécies de helmintos identificadas observou-se superioridade da associação Albendazole, Levamisole e Ivermectina. Até mesmo contra Haemonchus contortus a eficácia da associação (93%) foi superior à Moxidectina 1% (51,4%). No segundo teste, foram utilizadas 27 fêmeas ovinas de diferentes categorias (borregas e ovelhas) distribuídas nos três tratamentos experimentais previamente citados, com nove animais cada. Foram avaliados três dias após o tratamento (DPT) e, repetidas no 7o, 14o e 24o DPT, além dos parâmetros parasitológicos, as concentrações séricas do ferro, cobre e cobalto e a variação de peso corporal das fêmeas ovinas. Novamente a associação anti-helmíntica mostrou-se estatisticamente superior (P<0,05) no controle da verminose. A concentração sérica de ferro foi superior nos ovinos tratados com Moxidectina 1%, enquanto, os níveis de cobre e cobalto foram superiores nos ovinos que receberam Albendazole, Levamisole e Ivermectina. / Two experiments with sheep naturally infected by gastrointestinal nematodes were carried out to compare the anthelminthic efficacy of the association Albendazol, Levamisol and Ivermectin to 1% Moxidectin. In the first experiment, 24 sheep were distributed in three treatments with eight animals each: T1 treatment with the association Albendazol, Levamisol and Ivermectin; T2 treatment with 1% Moxidectin; T3 untreated control. Egg counts were performed 1, 3, 5 and 7 days after treatment, and results were expressed as eggs per gram of feces (EPG). On the day of the last egg count, sheep were submitted to necropsy and all helminths found in the gastrointestinal tract were counted and identified (genus and species). The association Albendazol, Levamisol and Ivermectin has shown to be more efficient in reducing EPG and the population of helminth species, even Haemonchus contortus, with a control rate of 93% against 51.4% of Moxidectin. In the second experiment, 27 female sheep of different categories (ewe lambs and ewe) were distributed in the same treatments described above. Parasitological parameters, body weight variation and iron, copper and cobalt concentrations in the serum were determined three days after treatment (DAT), 7th, 14th and 24th DAT. Again, the anthelminthic association was significantly superior (P<0.05) to control helminth parasites. The concentration of iron was higher in serum of animals treated with 1% Moxidectin, while the levels of copper and cobalt were higher in animals treated with Albendazol, Levamisol and Ivermectin. No significant differences were observed for weight variation or animal age. The results from both experiments showed that the association Albendazol, Levamisol and Ivermectin was more efficient in controlling and treating gastrointestinal helminthosis of naturally infected sheep.

Resumo: Para avaliar a eficácia anti-helmíntica da associação Albendazole, Levamisole e Ivermectina comparativamente a Moxidectina 1% foram realizados dois experimentos utilizando ovinos naturalmente infectados por nematódeos gastrintestinais. No primeiro teste, 24 ovinos foram distribuídos em três tratamentos experimentais com oito animais cada, assim definidos: T1 ovinos tratados com a associação Albendazole, Levamisole e Ivermectina; T2 ovinos tratados com Moxidectina 1% e T3 ovinos sem tratamento anti-helmíntico (controle). Contagens de ovos por grama de fezes (OPG) foram realizadas nos dias 1, 3, 5 e 7 após os tratamentos e, nesta última data, todos os ovinos foram necropsiados, sendo quantificados e identificados, quanto ao gênero e espécie, todos os helmintos encontrados no trato gastrintestinal. Tanto na redução de OPG quanto na eficácia contra as diferentes espécies de helmintos identificadas observou-se superioridade da associação Albendazole, Levamisole e Ivermectina. Até mesmo contra Haemonchus contortus a eficácia da associação (93%) foi superior à Moxidectina 1% (51,4%). No segundo teste, foram utilizadas 27 fêmeas ovinas de diferentes categorias (borregas e ovelhas) distribuídas nos três tratamentos experimentais previamente citados, com nove animais cada. Foram avaliados três dias após o tratamento (DPT) e, repetidas no 7o, 14o e 24o DPT, além dos parâmetros parasitológicos, as concentrações séricas do ferro, cobre e cobalto e a variação de peso corporal das fêmeas ovinas. Novamente a associação anti-helmíntica mostrou-se estatisticamente superior (P<0,05) no controle da verminose. A concentração sérica de ferro foi superior nos ovinos tratados com Moxidectina 1%, enquanto, os níveis de cobre e cobalto foram superiores nos ovinos que receberam Albendazole, Levamisole e Ivermectina. / Abstract: Two experiments with sheep naturally infected by gastrointestinal nematodes were carried out to compare the anthelminthic efficacy of the association Albendazol, Levamisol and Ivermectin to 1% Moxidectin. In the first experiment, 24 sheep were distributed in three treatments with eight animals each: T1 treatment with the association Albendazol, Levamisol and Ivermectin; T2 treatment with 1% Moxidectin; T3 untreated control. Egg counts were performed 1, 3, 5 and 7 days after treatment, and results were expressed as eggs per gram of feces (EPG). On the day of the last egg count, sheep were submitted to necropsy and all helminths found in the gastrointestinal tract were counted and identified (genus and species). The association Albendazol, Levamisol and Ivermectin has shown to be more efficient in reducing EPG and the population of helminth species, even Haemonchus contortus, with a control rate of 93% against 51.4% of Moxidectin. In the second experiment, 27 female sheep of different categories (ewe lambs and ewe) were distributed in the same treatments described above. Parasitological parameters, body weight variation and iron, copper and cobalt concentrations in the serum were determined three days after treatment (DAT), 7th, 14th and 24th DAT. Again, the anthelminthic association was significantly superior (P<0.05) to control helminth parasites. The concentration of iron was higher in serum of animals treated with 1% Moxidectin, while the levels of copper and cobalt were higher in animals treated with Albendazol, Levamisol and Ivermectin. No significant differences were observed for weight variation or animal age. The results from both experiments showed that the association Albendazol, Levamisol and Ivermectin was more efficient in controlling and treating gastrointestinal helminthosis of naturally infected sheep. / Orientador: Américo Garcia da Silva Sobrinho / Coorientador: Alvimar José da Costa / Banca: Gilson Pereira de Oliveira / Banca: Odilon Vidotto / Mestre

Made available in DSpace on 2016-01-26T18:55:27Z (GMT). No. of bitstreams: 1 ARTIGO FINAL_02_02_09.pdf: 347998 bytes, checksum: 56e6a67c83644f58e3352638f56c4d37 (MD5) Previous issue date: 2009-02-02 / The aim of this study was to evaluate the effect of levamisole on the antirabies humoral immune response in bovines primovaccinated against rabies. Forty-two bovines, about twelve months old, were randomly divided into three groups. Animals from VL group received one dose of levamisole and antirabies vaccine on day zero. Cattle from group V7L received one dose of antirabies vaccine on day zero and, on day seven, one dose of levamisole. Bovines from control group (GC) were immunized with just one dose of antirabies vaccine on day zero. A lyophilized, inactivated rabies vaccine, developed at Instituto Butantan was used. Blood samples were taken on days zero, 30 and 60. The neutralizing antibody titers were determined by serum neutralization in BHK21 cells, based on the Rapid Fluorescent Focus Inhibition Test (RFFIT) and on the Fluorescent Inhibition Microtest (FMIT). The results obtained showed that there was not significant difference in neutralizing-antibody titers and neither in the frequency of immunized animals between groups treated and not treated with levamisole 30 and 60 days after antirabies vaccination. In conclusion, levamisole administration (6.0 mg/kg of body weight) in primovaccinated bovines against rabies did not influence the antirabies humoral immune response. / O objetivo desse estudo foi avaliar o efeito do levamisol na resposta imune humoral anti-rábica de bovinos primovacinados contra a raiva. Quarenta e dois bovinos, com idade média de 12 meses, foram divididos aleatoriamente em três grupos. Os animais do grupo VL receberam uma dose de levamisol e vacina anti-rábica no dia zero. Nos bovinos do grupo V7L foi aplicada uma dose de vacina no dia zero e, no dia 7, uma dose de levamisol. Nos bovinos do grupo controle (GC), somente uma dose de vacina no dia zero. Utilizou-se uma vacina anti-rábica inativada, liofilizada, desenvolvida pelo Instituto Butantan. Colheram-se amostras de sangue nos dias zero, 30 e 60. Os títulos de anticorpos neutralizantes anti-rábicos foram determinados por meio da técnica de soroneutralização em células BHK21, baseado no Rapid Fluorescent Focus Inhibition Test (RFFIT) e no Fluorescent Inhibition Microtest (FIMT). Os resultados obtidos mostraram que não houve diferença significativa nos títulos de anticorpos anti-rábicos e nem na freqüência de animais imunizados entre os grupos tratados ou não com levamisol 30 e 60 dias após a vacinação anti-rábica. Conclui-se que a administração de levamisol (6,0 mg/Kg de peso vivo) em bovinos primovacinados contra a raiva, não influenciou a resposta imune humoral anti-rábica.

Made available in DSpace on 2016-07-18T17:53:05Z (GMT). No. of bitstreams: 1 ARTIGO FINAL_02_02_09.pdf: 347998 bytes, checksum: 56e6a67c83644f58e3352638f56c4d37 (MD5) Previous issue date: 2009-02-02 / The aim of this study was to evaluate the effect of levamisole on the antirabies humoral immune response in bovines primovaccinated against rabies. Forty-two bovines, about twelve months old, were randomly divided into three groups. Animals from VL group received one dose of levamisole and antirabies vaccine on day zero. Cattle from group V7L received one dose of antirabies vaccine on day zero and, on day seven, one dose of levamisole. Bovines from control group (GC) were immunized with just one dose of antirabies vaccine on day zero. A lyophilized, inactivated rabies vaccine, developed at Instituto Butantan was used. Blood samples were taken on days zero, 30 and 60. The neutralizing antibody titers were determined by serum neutralization in BHK21 cells, based on the Rapid Fluorescent Focus Inhibition Test (RFFIT) and on the Fluorescent Inhibition Microtest (FMIT). The results obtained showed that there was not significant difference in neutralizing-antibody titers and neither in the frequency of immunized animals between groups treated and not treated with levamisole 30 and 60 days after antirabies vaccination. In conclusion, levamisole administration (6.0 mg/kg of body weight) in primovaccinated bovines against rabies did not influence the antirabies humoral immune response. / O objetivo desse estudo foi avaliar o efeito do levamisol na resposta imune humoral anti-rábica de bovinos primovacinados contra a raiva. Quarenta e dois bovinos, com idade média de 12 meses, foram divididos aleatoriamente em três grupos. Os animais do grupo VL receberam uma dose de levamisol e vacina anti-rábica no dia zero. Nos bovinos do grupo V7L foi aplicada uma dose de vacina no dia zero e, no dia 7, uma dose de levamisol. Nos bovinos do grupo controle (GC), somente uma dose de vacina no dia zero. Utilizou-se uma vacina anti-rábica inativada, liofilizada, desenvolvida pelo Instituto Butantan. Colheram-se amostras de sangue nos dias zero, 30 e 60. Os títulos de anticorpos neutralizantes anti-rábicos foram determinados por meio da técnica de soroneutralização em células BHK21, baseado no Rapid Fluorescent Focus Inhibition Test (RFFIT) e no Fluorescent Inhibition Microtest (FIMT). Os resultados obtidos mostraram que não houve diferença significativa nos títulos de anticorpos anti-rábicos e nem na freqüência de animais imunizados entre os grupos tratados ou não com levamisol 30 e 60 dias após a vacinação anti-rábica. Conclui-se que a administração de levamisol (6,0 mg/Kg de peso vivo) em bovinos primovacinados contra a raiva, não influenciou a resposta imune humoral anti-rábica.